What does CUSIP 65343E108 represent in this 13F holders report?

CUSIP 65343E108 is the security identifier for NXTC - NextCure, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

How many institutions held NXTC - NextCure, Inc. - Common Stock, par value $0.001 per share in Q2 2023?

42 institutional investors reported NXTC - NextCure, Inc. - Common Stock, par value $0.001 per share for Q2 2023. Use the holders table for investor-level position and value details.

NextCure, Inc. - Common Stock, par value $0.001 per share (NXTC)

CUSIP: 65343E108

Q2 2023 13F Holders as of 30 Jun 2023

Security type / class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 3,602,511
Total 13F shares: 13,318,875
Share change: +53,602
Total reported value: $23,971,765
Reported price per share: $1.80
Number of holders: 42
Value change: +$169,807
Number of buys: 11
Number of sells: 15

Security key

65343E108

Report period

Q2 2023

Institutions

Top holders

NXTC full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2023 Previous quarter: Q1 2023 NextCure, Inc. SEC filings NextCure, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 65343E108

Newer quarter: Q3 2023 Previous quarter: Q1 2023

Recent filing periods:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Ownership snapshot

Top shareholders of NXTC - NextCure, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder

ORBIMED ADVISORS LLC

13D/G signal

—

Evidence rows

Latest as of

22 Jun 2023

13F 3/4/5 Lead comparable stake: 75% Showing first 8 of 47 holder rows. Open remaining rows

Rank 1 holder

ORBIMED ADVISORS LLC

13F

Ownership: 75%
Position: $4.01M

13F

Rank 2 holder

Sofinnova Investments, Inc.

13F

Ownership: 74%
Position: $3.95M

13F

Rank 3 holder

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ORBIMED ADVISORS LLC	13F Company 13F	75%	$4,012,299 2,711,013 shares	—	31 Mar 2023
Sofinnova Investments, Inc.	13F Company 13F	74%	$3,954,347 2,671,856 shares	—	31 Mar 2023
MILLENNIUM MANAGEMENT LLC	13F Company 13F	40%	$2,152,000 1,454,020 shares	—	31 Mar 2023
BlackRock Finance, Inc.	13F Company 13F	26%	$1,368,147 924,423 shares	—	31 Mar 2023
VANGUARD GROUP INC	13F Company 13F	25%	$1,344,540 908,473 shares	—	31 Mar 2023
Long Focus Capital Management, LLC	13F Company 13F	15%	$823,035 556,105 shares	—	31 Mar 2023
ACADIAN ASSET MANAGEMENT LLC	13F Company 13F	14%	$721,000 488,440 shares	—	31 Mar 2023
CITADEL ADVISORS LLC	13F Company 13F	13%	$710,173 479,847 shares	—	31 Mar 2023

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
TANG CAPITAL MANAGEMENT LLC	13F Company 13F	11%	$592,000 400,000 shares	—	31 Mar 2023
FEDERATED HERMES, INC.	13F Company 13F	11%	$575,082 388,569 shares	—	31 Mar 2023
BML Capital Management, LLC	13F Company 13F	8.5%	$453,568 306,465 shares	—	31 Mar 2023
RENAISSANCE TECHNOLOGIES LLC	13F Company 13F	6.8%	$362,000 244,500 shares	—	31 Mar 2023
DIMENSIONAL FUND ADVISORS LP	13F Company 13F	5.7%	$303,722 205,218 shares	—	31 Mar 2023
DAFNA Capital Management LLC	13F Company 13F	5.2%	$277,790 187,696 shares	—	31 Mar 2023
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	4.7%	$249,384 168,503 shares	—	31 Mar 2023
MACQUARIE GROUP LTD	13F Company 13F	4.2%	$222,000 150,000 shares	—	31 Mar 2023
Sio Capital Management, LLC	13F Company 13F	3.6%	$192,400 130,000 shares	—	31 Mar 2023
MORGAN STANLEY	13F Company 13F	3.3%	$175,143 118,340 shares	—	31 Mar 2023
TWO SIGMA ADVISERS, LP	13F Company 13F	3%	$158,064 106,800 shares	—	31 Mar 2023
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F Company 13F	2.6%	$140,008 94,600 shares	—	31 Mar 2023
GOLDMAN SACHS GROUP INC	13F Company 13F	2.6%	$138,347 93,478 shares	—	31 Mar 2023
BARCLAYS PLC	13F Company 13F	1.9%	$99,971 67,548 shares	—	31 Mar 2023
STATE STREET CORP	13F Company 13F	1.6%	$84,496 57,092 shares	—	31 Mar 2023
NORGES BANK	13F Company 13F	1.4%	$76,812 51,900 shares	—	31 Mar 2023
Marquette Asset Management, LLC	13F Company 13F	1.4%	$76,109 51,425 shares	—	31 Mar 2023
NORTHERN TRUST CORP	13F Company 13F	1.2%	$63,661 43,014 shares	—	31 Mar 2023
Minerva Advisors LLC	13F Company 13F	0.88%	$46,935 31,713 shares	—	31 Mar 2023
ExodusPoint Capital Management, LP	13F Company 13F	0.87%	$47,000 31,491 shares	—	31 Mar 2023
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F Company 13F	0.78%	$41,755 28,213 shares	—	31 Mar 2023
FRANKLIN RESOURCES INC	13F Company 13F	0.68%	$36,497 24,660 shares	—	31 Mar 2023
FMR LLC	13F Company 13F	0.56%	$29,747 20,099 shares	—	31 Mar 2023
HSBC HOLDINGS PLC	13F Company 13F	0.48%	$25,697 17,363 shares	—	31 Mar 2023
Tower Research Capital LLC (TRC)	13F Company 13F	0.39%	$21,000 14,100 shares	—	31 Mar 2023
UBS Group AG	13F Company 13F	0.35%	$18,851 12,737 shares	—	31 Mar 2023
HARBOURVEST PARTNERS LLC	13F Company 13F	0.28%	$14,865 10,044 shares	—	31 Mar 2023
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F Company 13F	0.28%	$14,800 10,000 shares	—	31 Mar 2023
JPMORGAN CHASE & CO	13F Company 13F	0.08%	$4,000 2,923 shares	—	31 Mar 2023
GROUP ONE TRADING LLC	13F Company 13F	0.02%	$1,252 846 shares	—	31 Mar 2023
Cutler Group LLC / CA	13F Company 13F	0.02%	$1,000 700 shares	—	31 Mar 2023
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO	13F Company 13F	0.02%	$814 550 shares	—	31 Mar 2023
BNP PARIBAS FINANCIAL MARKETS	13F Company 13F	0.01%	$570 385 shares	—	31 Mar 2023
WELLS FARGO & COMPANY/MN	13F Company 13F	0%	$185 125 shares	—	31 Mar 2023
BANK OF AMERICA CORP /DE/	13F Company 13F	0%	$3 3 shares	—	31 Mar 2023
Linda Liu	3/4/5 SVP, Research 3/4/5	— class O/S missing	— 65,600 shares	—	31 Jan 2022
Chau Q. Khuong	3/4/5 Director 3/4/5	— class O/S missing	— 14,250 shares	—	22 Jun 2023
Garry A. Nicholson	3/4/5 Director 3/4/5	— class O/S missing	— 14,250 shares	—	22 Jun 2023
Stella Xu	3/4/5 Director 3/4/5	— class O/S missing	— 14,250 shares	—	24 Jun 2021

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

13,318,875

Rows loaded

Investor	Option	Weight %	Change %	Reported value	* Price	Shares	Share Change	Activity	Report Period

^* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Q2 2023 holders

Holder diff

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 value	Q2 2023 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

NextCure, Inc. - Common Stock, par value $0.001 per share (NXTC)

Q2 2023 13F Holders as of 30 Jun 2023

Holder history for CUSIP 65343E108

Top shareholders of NXTC - NextCure, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

ORBIMED ADVISORS LLC

Sofinnova Investments, Inc.

MILLENNIUM MANAGEMENT LLC

Institutional holders as of Q2 2023

Compare Q2 2023 vs Q1 2023 Across Filers